Yahoo Web Search

Search results

  1. Charles Weissmann (born 14 October 1931) is a Hungarian-Swiss molecular biologist. Weissmann is particularly known for the first cloning and expression of interferon and his contributions to the unraveling of the molecular genetics of neurogenerative prion diseases such as scrapie , Creutzfeldt–Jakob disease and " mad cow disease ".

  2. Photo of Dr. Charles Weissmann by Scripps Research Institute[/caption]Charles Weissmann was born on October 14, 1931, in Budapest, Hungary. He obtained his M.D. in 1956 and a Ph.D. in Organic Chemistry in 1961 from Zurich University. Dr. Weissmann was director of the Institute for Molecular Biology in Zurich and President of the Roche Research Foundation...

  3. Apr 2, 2012 · Eric Sauter of News&Views recently had the opportunity to chat with Charles Weissmann, chair of the Department of Infectology at Scripps Florida who is retiring April 30, about some of the experiences and insights he has gained during his 60-year career in research. You became interested in science at a young age.

  4. Charles Weissmann; Three commonly used isolates of murine prions, 79A, 139A, and RML, were derived from the so-called Chandler isolate, which was obtained by propagating prions from scrapie ...

    • Professor Emeritus
  5. Professor Charles Weissmann, M.D., Ph.D. is Professor emeritus, at Scripps Florida Research Institute. Born October 14, 1931, Weissman received his. M.D. (1956) and Ph.D. in Organic Chemistry (1961). He was assistant to Professor P. Karrer, U. of Zürich 1960-1961. Postdoctoral Fellow (1961-63), Instructor (1963-64), Assistant Professor (1964 ...

  6. Charles Weissman is a molecular geneticist who is best known for being the first to clone the genes for interferon, a protein released in response to viral infection that can now be synthesised on an industrial scale for use as a medicine. He went on to research a number of different disease-causing agents, or pathogens. He was the first to ...

  7. People also ask

  8. One key challenge, Weissmann says, is to generate measurable prion infectivity in vitro. Former colleagues are not surprised at Weissmann's unwillingness to rest on his laurels. “Charles is an incredibly rigorous person,” says Richard Flavell at Yale University. “He is almost obsessive about making sure that he is right.”.

  1. People also search for